Connect with us

Technology

TNL Mediagene Pursues Cost-Efficient Expansion with New C-Level Hires and Strategic M&A Focus

Published

on

NEW YORK and TOKYO, May 7, 2025 /PRNewswire/ — TNL Mediagene (Nasdaq: TNMG), a Tokyo-based next-generation digital media and data group in Asia, today announced its Strategic Expansion Plan comprising two pillars, Global Talent Management and Global Strategic M&A. The plan, spanning the next 24-month period, outlines the company’s focus on cost-efficient revenue growth, toward its goal of continued growth in revenue while further improving Adjusted EBITDA.

As part of its Global Talent Management pillar, the company announced the appointment of Aya Miyake as Chief Governance Officer and Carly Ma as Chief Human Resources Officer.

Aya Miyake brings over two decades of capital markets and business experience including executive roles at Tokyo Stock Exchange, Osaka Securities Exchange and Automotive Fund. Aya’s extensive experience includes corporate governance, public listings, capital raising, investor relations and compliance. Aya’s role as Chief Governance Officer at TNL Mediagene will strengthen the company’s expertise in public company matters and bolster its C-level oversight and control functions.

Carly Ma brings over a decade of HR experience at multinational corporations with roles at Porsche Taiwan Motors, a subsidiary of Porsche A.G. Germany, Amazon Fulfillment Services and Amazon Canada. Carly’s experience includes talent acquisition, talent optimization and corporate culture development programs. Carly’s experience at multinational companies will strengthen TNL Mediagene’s talent acquisition and talent optimization functions and align the company’s practices with best-practice international standards.

“Aya’s wealth of experience in the capital markets and adjacent areas will bolster our institutional knowledge in all areas of public company matters as well as enhance our C-level oversight and control functions. Carly’s experience in multinational corporate HR will bring HR best practices to our company, help us acquire and retain talent as well as optimize our talent pool going forward. We are thrilled to welcome them to the TNL Mediagene family” Co-Founder & CEO Joey Chung said.

As part of the Global Strategic M&A pillar, the company gave an update on its M&A strategy including its focus on enhancing revenue growth and revenue diversification via M&A. The company’s geographic focus areas for strategic expansion include the Southeast Asia, Japan and Taiwan markets where the company sees the highest ROI and synergy potential as well as English language markets such as the US, Canada, UK and Australia.

“M&A has been a part of our DNA for some time now. We have acquired and integrated 10 companies since 2018 and maintain an active pipeline of M&A opportunities. We have close relationships with our bankers and continue to actively screen targets with them. In the near-term we see opportunities in Southeast Asia, Japan and Taiwan and in the medium to longer-term we see opportunities in the US and other English language markets. Right now, we are most focused on assets that are complementary to our current businesses or assets where we can add value and enhance with our relative strengths in technology products, multilingualization or cost discipline. These can include, for example, assets with large regional audiences but less sophisticated tech, assets with a solid offering that we can expand into a new language market with our multilingualization strategies or assets where we can add value by taking cost out using our cost discipline strategies.”

TNL Mediagene believes M&A is a key component of its financial performance and intends to be acquisitive going forward.

“In FY2024 we achieved 35% revenue growth, a ~1% gross margin expansion to 36.6%, and a ~1% Adjusted EBITDA margin expansion to near break-even at -1.8%. We are proud of these results and believe they are a testament to our ability to grow our revenues while running our businesses in a cost-efficient manner. Strategic M&A has always been a part of that equation and we expect that to continue going forward” Joey concluded.

Summary Financials:

For the year ended December 31,

($ in dollars, unless otherwise stated)

2022

2023

2024

Revenue

20,009,994

35,838,780

48,493,897

Growth %

79.1 %

35.3 %

Gross Profit

7,741,196

12,651,384

17,738,557

Margin %

38.7 %

35.3 %

36.6 %

Adjusted EBITDA

-1,687,729

-998,162

-854,174

Margin %

-8.4 %

-2.8 %

-1.8 %

 

The condensed financial information presented in this press release should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2024 included in TNL Mediagene’s annual report on Form 20-F filed with the SEC on April 30, 2025, which provides a more complete discussion of its accounting policies and certain other information.

About TNL Mediagene

Headquartered in Tokyo, TNL Mediagene was formed in May 2023 through the merger of Taiwan’s The News Lens Co. and Japan’s Mediagene Inc., two of the region’s leading independent digital media groups. The company’s operations span original and licensed media brands in Japanese, Chinese, and English, covering topics such as news, business, technology, science, food, sports, and lifestyle. It also offers AI-driven advertising services, marketing technology platforms, e-commerce, and innovative solutions tailored to the needs of advertising agencies. Known for its political neutrality, appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 500 employees across Asia, with offices in Japan, Taiwan, and Hong Kong.

https://www.tnlmediagene.com/

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene’s future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements in the section entitled “2025 Initiatives and Outlook” and “Management Commentary” such as statements about TNL Mediagene’s future business plan and growth strategies and statements by TNL Mediagene’s CEO and president. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene’s filings with the Securities and Exchange Commission. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.

Use of Non-IFRS Financial Measures
In this press release we have included adjusted EBITDA, a non-IFRS financial measure, which is a key measure used by our management and board of directors in evaluating our operating performance.

Adjusted EBITDA is our preferred metric for profitability because we believe it facilitates operating performance comparisons on a period-to-period basis and excludes items that we do not consider to be indicative of our core operating performance.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under IFRS. Some of these limitations are:

although amortization and depreciation are non-cash charges, the assets being amortized and depreciated may have to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation; andother companies, including our competitors in various industries, may calculate adjusted EBITDA or similarly titled measures differently, which reduces its usefulness as a comparative measure.

We define adjusted EBITDA as profit (loss) for the period excluding (i) non-cash items such as depreciation expenses, amortization expenses, stock-based compensation expenses and impairment loss on intangible assets and (ii) extraordinary items associated with one-time events and transactions, such as one-time transaction-related expenses not eligible for capitalization.

Reconciliation of Non-IFRS Financial Measures:

For the year ended December 31,

($ in dollars, unless otherwise stated)

2022

2023

2024

Loss for the year

$

(11,394,768)

$

(1,215,789)

$(84,976,720)

Add (less):

Income tax (benefit) expense

(247,177)

(591,082)

(307,246)

Finance costs

137,029

298,958

8,167,872

Other gains and losses(1)

8,174,802

(5,458,803)

851,689

Other income

(75,576)

(409,555)

(58,024)

Interest Income

(10,994)

(19,340)

(21,773)

Operating loss

$

(3,416,684)

$

(7,395,611)

$(76,344,202)

Add:

Depreciation expenses

433,262

1,025,783

1,139,488

Amortization expenses

1,058,392

1,809,774

2,101,080

Stock-based compensation expense

237,301

118,800

250,952

Impairment loss on intangible assets(2)

298,424

29,026,050

One-time transaction-related expenses(3)

3,144,668

42,972,458

Adjusted EBITDA

(1,687,729)

(998,162)

(854,174)

Adjusted EBITDA Margin (%)

-8.4

%

-2.8

%

-1.8

%

(1)

Other gains and losses for the year ended December 31, 2022 comprise an $8.2 million loss mainly attributed to a change in the fair value through profit and loss (“FVPTL”) associated with our convertible preference shares. Other gains and losses for the year ended December 31, 2023 comprise a $5.5 million gain mainly attributed to a change in the FVPTL associated with the conversion of all of our preference shares into our ordinary shares at a lower fair value during the year ended December 31, 2023. Other gains and losses for the year ended December 31, 2024 comprise a $0.8 million loss mainly attributed to a change in FVTPL associated with the convertible promissory note and warrants.

(2)

For the year ended December 31, 2023, we incurred approximately $0.3 million of impairment loss on intangible assets due to the closure of our e-commerce platform CoSTORY as the internally-developed software on which CoSTORY relied became no longer recoverable. For the year ended December 31, 2024, we incurred impairment loss on intangible assets of approximately $29.0 million, which mainly consisted of (i) an impairment loss of $25.5 million against the goodwill of Mediagene recognized because, following the merger with Mediagene in May 2023 and during subsequent operations in 2024, it became evident that the anticipated synergies fell short of initial expectations due to changes in the overall environment, necessitating adjustments to the financial projections and, as a result of this downward revision in projected future revenues, the fair value declined, leading to the recognition of an impairment loss and (ii) an impairment loss of $3.1 million due to the downsizing of the e-commerce department of Polydice Inc. 

(3)

For the year ended December 31, 2023, one-time transaction-related expenses comprise the professional service fees related to (i) the merger with Mediagene; and (ii) preparation for our merger (the “Merger”) with Blue Ocean Acquisition Corporation (“Blue Ocean”) and the listing on the Nasdaq, which were not eligible for capitalization. For the year ended December 31, 2024, one-time transaction-related expenses comprise (i) the professional service fees related to the closing of the Merger and listing on the Nasdaq of $4.3 million; (ii) the professional service fees related to the acquisition of Green Quest Holdings, Inc. of $0.5 million; and (iii) the listing expense of $38.2 million from the excess of the fair value of TNL Mediagene Ordinary Shares issued over the fair value of Blue Ocean’s identifiable net assets on the Closing Date of the Merger, each of which was not eligible for capitalization.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tnl-mediagene-pursues-cost-efficient-expansion-with-new-c-level-hires-and-strategic-ma-focus-302448766.html

SOURCE TNL Mediagene

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Media Advisory – Minister Hodgson to deliver keynote speech on One Year of Nation Building

Published

on

By

TORONTO, April 22, 2026 /CNW/ – The Minister of Energy and Natural Resources, the Honourable Tim Hodgson, will speak at the Empire Club of Canada regarding this past year’s accomplishments and future strategic directions.

Date: April 24, 2026

Time: 11:30 a.m. ET

All accredited media are asked to register using the Empire Club’s press accreditation and registration form. Details on how to participate will be provided upon registration.

Follow Natural Resources Canada on LinkedIn.

SOURCE Natural Resources Canada

Continue Reading

Technology

Harness Delivers Unified AI Intelligence Across Software Delivery with Google Cloud

Published

on

By

Harness integrates Google Cloud’s Developer Connect into its Software Delivery Knowledge Graph to give engineering teams smarter, faster AI-driven insights

SAN FRANCISCO, April 22, 2026 /PRNewswire/ — Harness, the AI Software Delivery Platform™ company, today announced that it will bring together Harness’s Software Delivery Knowledge Graph and Google Cloud’s Developer Connect. The initiative gives joint customers a unified, AI-ready view of their entire software delivery lifecycle, and the intelligence to act on it with confidence.

The announcement was made at Google Cloud Next, where Harness also won the 2026 Google Cloud Technology Partner of the Year Award in the Application Development – DevOps category.

The Missing Piece in AI Software Delivery

Modern software delivery environments are inherently complex. Pipelines, services, build and deploy infrastructure, artifacts, and dependencies are deeply interconnected — and the data that describes how they relate to one another is scattered across dozens of tools. As organizations accelerate their adoption of AI-powered engineering, that fragmentation becomes a critical liability. AI is only as effective as the context it can access, and today, most AI agents are operating with an incomplete picture.

Harness is addressing this challenge head-on. By integrating Google Cloud Developer Connect insights into the Harness Software Delivery Knowledge Graph, joint customers gain a continuously updated, relationship-aware model of their software delivery environment that spans both platforms, bridging the visibility gap between development and production so that AI agents can operate with complete and reliable context. For engineering teams, this translates directly to making decisions grounded in situational awareness rather than generic training data, allowing them to execute complex workflows with greater accuracy.

Where the Partnership Comes to Life

For joint customers of Harness and Google Cloud, this integration means Harness AI can now make smarter, faster decisions on their behalf. By bringing together deployment event logs, runtime data, and application dependency information from Google Cloud into the Harness Software Delivery Knowledge Graph, teams gain a continuously updated, comprehensive view of their software delivery environment. When an issue arises, engineers can diagnose and remediate faster, trace problems back to specific source files or infrastructure, and link artifacts to the teams responsible for them, without having to manually piece together context from multiple systems.

The result is AI that works harder for customers. With richer context available upfront, AI agents can operate more efficiently, delivering answers and recommendations that reflect the true state of the environment. Everything teams need is in one place, and their AI has everything it needs to act on it confidently.

Security is central to how this integration was built. Data shared between Harness and Google Cloud is governed by enterprise-grade access controls, ensuring the right information reaches the right people within the guardrails organizations require.

“AI is only as powerful as the context behind it. Without it, teams fall into the AI Velocity Paradox: moving code faster than ever, but risking shipping software that is unverified, insecure, and unreliable,” said Jyoti Bansal, co-founder and CEO of Harness. “This is exactly what our expanded work with Google Cloud directly addresses, giving joint customers a unified view of their software delivery environment and AI that can actually reason across it. When context is complete, speed and confidence go hand in hand.”

A Collaboration That Keeps Deepening

This integration is the latest evolution of a long-standing collaboration between Harness and Google Cloud. Harness AI runs on Gemini Enterprise Agent Platform, and joint customers already benefit from expanded access through Google Cloud Marketplace. With this announcement, that work expands from the infrastructure layer into the application layer — and directly into how AI understands and acts on the software delivery environment. And it doesn’t stop there. The Harness MCP Server is now accessible within Google’s Gemini Enterprise app environment, enabling Gemini Enterprise customers to leverage Harness capabilities directly from their existing AI interface.

“Google Cloud provides cutting-edge technology that helps partners innovate and deliver more impactful solutions for business transformation,” said Ritika Suri, Managing Director, AI and Data Partnerships at Google Cloud. “Through our partnership with Harness, we will provide customers with innovative capabilities that can improve operations, enhance customer experiences, and drive innovation.”

Join Us

As our Knowledge Graph ecosystem continues to grow, Harness remains committed to expanding the breadth of integrations available to customers with the goal of being the most comprehensive AI-ready software delivery platform on the market.

To connect with the Harness team in person, visit the Harness booth at Google Cloud Next.

About Harness
Harness is the AI Software Delivery Platform™ company, enabling engineering teams to build, test, and deliver software faster and more securely. Powered by Harness AI and the Software Delivery Knowledge Graph, the platform brings intelligent automation to every stage of the software delivery lifecycle after code — removing toil and freeing developers from manual, repetitive work. Companies like United Airlines, Morningstar, and Choice Hotels use Harness to deploy up to 70% faster, reduce change failure rates by 50%, cut deployment effort by 80%, and lower security noise by 65%. Based in San Francisco, Harness is backed by Menlo Ventures, IVP, Unusual Ventures, and Citi Ventures.

View original content to download multimedia:https://www.prnewswire.com/news-releases/harness-delivers-unified-ai-intelligence-across-software-delivery-with-google-cloud-302749850.html

SOURCE Harness

Continue Reading

Technology

H.I.G. Capital Announces the Sale of Celerion

Published

on

By

MIAMI, April 22, 2026 /PRNewswire/ — H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce that one of its affiliates has signed a definitive agreement to sell its portfolio company, Celerion Holdings, Inc. (“Celerion” or the “Company”), a global CRO and leader in clinical pharmacology and bioanalytical sciences, to funds affiliated with THL Partners (“THL”).

Headquartered in Lincoln, Nebraska, Celerion is a leading provider of highly specialized clinical pharmacology and bioanalytical sciences with deep expertise in first-in-human dose escalation, cardiac safety (TQT), drug-drug interaction, and other complex clinical pharmacology studies that support regulatory approval and drug labeling. Celerion offers an integrated suite of services spanning data management, biostatistics, and clinical monitoring that supports a global base of pharmaceutical and biotechnology customers through its purpose-built clinical and laboratory infrastructure with facilities in Lincoln, Phoenix, Zurich, and Belfast.

H.I.G. acquired Celerion in November 2022 and worked closely with management to accelerate growth and strengthen the Company’s market position. During its ownership, H.I.G. supported strategic investments across commercial, operational, and technology initiatives, including the expansion of Celerion’s clinical and bioanalytical laboratory footprint. These efforts drove exceptional growth and solidified Celerion’s standing as a leading, clinical pharmacology-focused, contract research organization.

Susan Thornton, Celerion’s President & CEO, commented, “H.I.G. has been an exceptional partner to Celerion, helping us accelerate key strategic initiatives and invest meaningfully in our people, capabilities, and infrastructure. These efforts have strengthened our platform and enhanced the quality and consistency of outcomes we deliver to customers. We are excited to carry this momentum forward with THL as we enter our next phase of growth.”

Mike Gallagher, Managing Director at H.I.G., commented, “We are proud of what Celerion’s best-in-class team has accomplished during our partnership. The team has delivered industry- leading growth during our ownership, and we are confident it is uniquely positioned for its next chapter.”

Michael Kuritzky, Managing Director at H.I.G., added, “We are very proud of the work Celerion does to help drug sponsors worldwide navigate the complexities of clinical trial management. It has been a privilege to partner with Susan and her team, and we look forward to Celerion’s continued success.”

BofA Securities, Inc. and Lazard Frères & Co. LLC were financial advisors to H.I.G. and Celerion. McDermott Will & Schulte LLP was legal counsel for H.I.G. and Celerion in connection with the transaction.

About Celerion

Celerion is a clinical research organization that provides comprehensive clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research throughout North America, Europe, and Asia. The Company serves its clients through a global network of facilities and provides first-in-human to proof-of-concept studies as well as bioanalytical laboratory services, data management and biometrics, and drug development services. For more information, visit celerion.com.

About H.I.G. Capital

H.I.G. Capital is a leading global alternative investment firm with $74 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco, and Stamford in the United States, as well as international affiliate offices in Hamburg, London, Luxembourg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, São Paulo, Dubai, and Hong Kong, H.I.G. specializes in providing both debt and equity capital to middle market companies, utilizing a flexible and operationally focused/value-added approach:

H.I.G.’s equity funds invest in management buyouts, recapitalizations, and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.H.I.G.’s debt funds invest in senior, unitranche, and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. also manages a publicly traded BDC, WhiteHorse Finance.H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.

Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The Firm’s current portfolio includes more than 100 companies with combined sales in excess of $53 billion. For more information, please refer to the H.I.G. website at hig.com.

*Based on total capital raised by H.I.G. Capital and its affiliates.

Contact:

Mike Gallagher
Managing Director
mgallagher@hig.com

Michael Kuritzky
Managing Director
mkuritzky@hig.com

Alex Zisson
Managing Director
azisson@hig.com

H.I.G. Capital
1450 Brickell Avenue
31st Floor
Miami, FL 33131
P: 305.379.2322
hig.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/hig-capital-announces-the-sale-of-celerion-302749396.html

SOURCE H.I.G. Capital

Continue Reading

Trending